Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIMS Lenses vs Monofocal Lenses + Atropine 0.05% in Myopia Control in Children
NCT05062031Completed
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Oct 2021
- Primary completion
- Feb 2026
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of NVK002 in myopia (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoints: Axial length measurements at 24 months and Spherical equivalent at 24 months. Started Oct 2021; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05062031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062031.